Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
Integration of Electrospun Scaffolds and Biological Polymers for Enhancing the Delivery and Efficacy of Mesenchymal Stem/Stromal Cell Therapies, Allan John R Barcena, Archana Mishra, Dominic Karl M Bolinas, et al.
Controlled Delivery of Rosuvastatin or Rapamycin through Electrospun Bismuth Nanoparticle-Infused Perivascular Wraps Promotes Arteriovenous Fistula Maturation, Allan John R Barcena, Joy Vanessa D Perez, Marvin R Bernardino, et al.
Emerging Biomedical and Clinical Applications of 3D-Printed Poly(Lactic Acid)-Based Devices and Delivery Systems, Allan John R Barcena, Prashanth Ravi, Suprateek Kundu, et al.
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study, Aditya Bardia, Ian E Krop, Takahiro Kogawa, et al.
ARID1A Orchestrates Swi/Snf-Mediated Sequential Binding of Transcription Factors With ARID1A Loss Driving Pre-Memory B Cell Fate and Lymphomagenesis, Darko Barisic, Christopher R Chin, Cem Meydan, et al.
Tumor-Infiltrating Nerves Functionally Alter Brain Circuits and Modulate Behavior in a Mouse Model of Head-and-Neck Cancer, Jeffrey Barr, Austin Walz, Anthony C Restaino, et al.
Human Minor Salivary Glands: A Readily Available Source of Salivary Stem/Progenitor Cells for Regenerative Applications, Caitlynn M L Barrows, Danielle Wu, Simon Young, et al.
Chronic Wasting Disease: State of the Science, Jason C Bartz, Rebeca Benavente, Byron Caughey, et al.
Evaluation of a Tiered Opioid Prescription Algorithm in an Eras Pathway: Exploring Opportunities for Further Refinement, M Sol Basabe, Tina S Suki, Mark F Munsell, et al.
Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes, Reva K Basho, Li Zhao, Jason B White, et al.
Myeloid Lineage Switch in KMT2A- Rearranged Acute Lymphoblastic Leukemia Treated With Lymphoid Lineagedirected Therapies, Alex Bataller, Tareq Abuasab, David McCall, et al.
Prognostic Risk Signature in Patients With Acute Myeloid Leukemia Treated With Hypomethylating Agents and Venetoclax, Alex Bataller, Alexandre Bazinet, Courtney D DiNardo, et al.
Targetable Genetic Abnormalities in Patients With Acute Myeloblastic Leukemia Across Age Groups, Alex Bataller, Courtney D DiNardo, Alexandre Bazinet, et al.
Therapy-Related Chronic Myelomonocytic Leukemia Does Not Have the High-Risk Features of a Therapy-Related Neoplasm, Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, et al.
Outcomes and Genetic Dynamics of Acute Myeloid Leukemia at First Relapse, Alex Bataller, Hagop Kantarjian, Alexandre Bazinet, et al.
Induction of Long-Term Hyperexcitability by Memory-Related cAMP Signaling in Isolated Nociceptor Cell Bodies, Alexis Bavencoffe, Michael Y Zhu, Sanjay V Neerukonda, et al.
New-Onset Diabetes Is a Predictive Risk Factor for Pancreatic Lesions in High-Risk Individuals: An Observational Cohort Study, Seyda Baydogan, Chirayu Mohindroo, Merve Hasanov, et al.
A Biogeographical Appraisal of the Threatened South East Africa Montane Archipelago Ecoregion, Julian Bayliss, Gabriela B Bittencourt-Silva, William R Branch, et al.
Ovarian Cancer Metastasis: Looking Beyond the Surface, Emine Bayraktar, Sisy Chen, Sara Corvigno, et al.
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study, Lyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, et al.
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax, Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, et al.
Oral Decitabine and Cedazuridine Plus Venetoclax for Older or Unfit Patients With Acute Myeloid Leukaemia: A Phase 2 Study, Alexandre Bazinet, Guillermo Garcia-Manero, Nicholas Short, et al.
Oral Decitabine and Cedazuridine Plus Venetoclax for Older or Unfit Patients With Acute Myeloid Leukaemia: A Phase 2 Study, Alexandre Bazinet, Guillermo Garcia-Manero, Nicholas Short, et al.
Reduced Dose Azacitidine Plus Venetoclax As Maintenance Therapy in Acute Myeloid Leukaemia Following Intensive or Low-Intensity Induction: A Single-Centre, Single-Arm, Phase 2 Trial, Alexandre Bazinet, Hagop Kantarjian, Alex Bataller, et al.
Persistent Tailoring of MSC Activation Through Genetic Priming, Michael A Beauregard, Guy C Bedford, Daniel A Brenner, et al.